KONINKLIJKE PHILIPS NV (PHI1.DE) Stock Fundamental Analysis
Europe - FRA:PHI1 - NL0000009538 - Common Stock
24.22 EUR
-0.2 (-0.82%)
PHI1 gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. PHI1 has a bad profitability rating. Also its financial health evaluation is rather negative. PHI1 has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year PHI1 was profitable.
PHI1 had a positive operating cash flow in the past year.
In multiple years PHI1 reported negative net income over the last 5 years.
Of the past 5 years PHI1 4 years had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 0.61%, PHI1 is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
PHI1's Return On Equity of 1.56% is on the low side compared to the rest of the industry. PHI1 is outperformed by 60.00% of its industry peers.
The Return On Invested Capital of PHI1 (4.00%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROIC | 4% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Profit Margin value of 0.91%, PHI1 is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Looking at the Operating Margin, with a value of 6.11%, PHI1 is in line with its industry, outperforming 45.00% of the companies in the same industry.
PHI1's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 43.85%, PHI1 is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of PHI1 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
PHI1 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
PHI1 has less shares outstanding than it did 1 year ago.
The number of shares outstanding for PHI1 has been increased compared to 5 years ago.
PHI1 has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.93 indicates that PHI1 is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.93, PHI1 perfoms like the industry average, outperforming 48.33% of the companies in the same industry.
The Debt to FCF ratio of PHI1 is 19.41, which is on the high side as it means it would take PHI1, 19.41 years of fcf income to pay off all of its debts.
PHI1 has a Debt to FCF ratio of 19.41. This is in the lower half of the industry: PHI1 underperforms 60.00% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that PHI1 is somewhat dependend on debt financing.
PHI1 has a Debt to Equity ratio of 0.69. This is in the lower half of the industry: PHI1 underperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Altman-Z | 1.93 |
ROIC/WACC0.63
WACC6.31%
2.3 Liquidity
A Current Ratio of 1.26 indicates that PHI1 should not have too much problems paying its short term obligations.
PHI1 has a worse Current ratio (1.26) than 63.33% of its industry peers.
A Quick Ratio of 0.81 indicates that PHI1 may have some problems paying its short term obligations.
PHI1 has a worse Quick ratio (0.81) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
PHI1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.16%, which is quite good.
The Earnings Per Share has been decreasing by -7.17% on average over the past years.
PHI1 shows a decrease in Revenue. In the last year, the revenue decreased by -0.81%.
PHI1 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.00% yearly.
EPS 1Y (TTM)12.16%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%0.5%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.14%
3.2 Future
The Earnings Per Share is expected to grow by 12.68% on average over the next years. This is quite good.
Based on estimates for the next years, PHI1 will show a small growth in Revenue. The Revenue will grow by 3.65% on average per year.
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 16.82, which indicates a correct valuation of PHI1.
86.67% of the companies in the same industry are more expensive than PHI1, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 25.83. PHI1 is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 15.83 indicates a correct valuation of PHI1.
71.67% of the companies in the same industry are more expensive than PHI1, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of PHI1 to the average of the S&P500 Index (32.68), we can say PHI1 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.82 | ||
| Fwd PE | 15.83 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHI1 indicates a somewhat cheap valuation: PHI1 is cheaper than 76.67% of the companies listed in the same industry.
PHI1's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.74 | ||
| EV/EBITDA | 12.54 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHI1 does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)70.79
PEG (5Y)N/A
EPS Next 2Y5.1%
EPS Next 3Y7.59%
5. Dividend
5.1 Amount
PHI1 does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:PHI1 (11/7/2025, 7:00:00 PM)
24.22
-0.2 (-0.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.54%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.32B
Revenue(TTM)18.02B
Net Income(TTM)162.00M
Analysts74.81
Price Target27.55 (13.75%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)0.97%
PT rev (3m)1.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.41%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-8.83%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-0.85%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-1.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.82 | ||
| Fwd PE | 15.83 | ||
| P/S | 1.31 | ||
| P/FCF | 53.74 | ||
| P/OCF | 21.22 | ||
| P/B | 2.25 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.54 |
EPS(TTM)1.44
EY5.95%
EPS(NY)1.53
Fwd EY6.32%
FCF(TTM)0.45
FCFY1.86%
OCF(TTM)1.14
OCFY4.71%
SpS18.54
BVpS10.78
TBVpS-1.76
PEG (NY)70.79
PEG (5Y)N/A
Graham Number18.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROCE | 5.69% | ||
| ROIC | 4% | ||
| ROICexc | 4.43% | ||
| ROICexgc | 14.55% | ||
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% | ||
| FCFM | 2.43% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Debt/EBITDA | 3.01 | ||
| Cap/Depr | 51.35% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 4 | ||
| Cash Conversion | 46.06% | ||
| Profit Quality | 267.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.93 |
F-Score8
WACC6.31%
ROIC/WACC0.63
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.16%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%0.5%
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.14%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.14%
EBIT Next 3Y21.01%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%
KONINKLIJKE PHILIPS NV / PHI1.DE FAQ
What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NV (PHI1.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to PHI1.DE.
What is the valuation status of KONINKLIJKE PHILIPS NV (PHI1.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHI1.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for KONINKLIJKE PHILIPS NV?
KONINKLIJKE PHILIPS NV (PHI1.DE) has a profitability rating of 2 / 10.
How financially healthy is KONINKLIJKE PHILIPS NV?
The financial health rating of KONINKLIJKE PHILIPS NV (PHI1.DE) is 2 / 10.
What is the earnings growth outlook for KONINKLIJKE PHILIPS NV?
The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NV (PHI1.DE) is expected to grow by 0.24% in the next year.